Major Depressive Disorder
|
0.380 |
GeneticVariation
|
disease |
BEFREE |
Several promising genes, such as the COMT (catechol-O-methyltransferase) gene, the serotonin transporter gene (SLC6A4), and neuropeptide Y (NPY) suggest gene × environment interaction between genetic variants, childhood adversity, and the occurrence of PTSD and MDD, indicating an impact of these genes on resilience.
|
31583809 |
2020 |
Major Depressive Disorder
|
0.380 |
Biomarker
|
disease |
BEFREE |
Both NPY and CGRP were higher in PD patients with comorbid depression compared to MDD patients.
|
28659833 |
2017 |
Major Depressive Disorder
|
0.380 |
Biomarker
|
disease |
PSYGENET |
A series of statistical methods was carried out to investigate the correlation between the NPY gene SNP and MDD.
|
23468908 |
2013 |
Major Depressive Disorder
|
0.380 |
GeneticVariation
|
disease |
BEFREE |
A series of statistical methods was carried out to investigate the correlation between the NPY gene SNP and MDD.
|
23468908 |
2013 |
Major Depressive Disorder
|
0.380 |
GeneticVariation
|
disease |
BEFREE |
To test this hypothesis, we compared plasma levels and affinities of NPY-reactive autoAbs between patients with major depression and healthy controls.
|
22365482 |
2012 |
Major Depressive Disorder
|
0.380 |
Biomarker
|
disease |
PSYGENET |
To test this hypothesis, we compared plasma levels and affinities of NPY-reactive autoAbs between patients with major depression and healthy controls.
|
22365482 |
2012 |
Major Depressive Disorder
|
0.380 |
Biomarker
|
disease |
PSYGENET |
Supporting studies in mutant mice models suggest a complex mechanism of low constitutive and activity-dependent BDNF function in MDD, particularly affecting SST/NPY-related GABA neurons, thus linking the neurotrophic and GABA hypotheses of depression.
|
21912391 |
2012 |
Major Depressive Disorder
|
0.380 |
Biomarker
|
disease |
PSYGENET |
In the GAIN MDD study, two SNPs were associated with MDD: C5orf20 (rs12520799; P=0.038; odds ratio (OR) AT=1.10, 95% CI 0.95-1.29; OR TT=1.21, 95% confidence interval (CI) 1.01-1.47) and NPY (rs16139; P=0.034; OR C allele=0.73, 95% CI 0.55-0.97), constituting a direct replication of previously identified SNPs.
|
20351714 |
2011 |
Major Depressive Disorder
|
0.380 |
GeneticVariation
|
disease |
BEFREE |
Among 44 individuals with MDD and 137 healthy controls, 152 (84%) had an NPY genotype classified as low, intermediate, or high expression according to previously established haplotype-based expression data.
|
21300944 |
2011 |
Major Depressive Disorder
|
0.380 |
GeneticVariation
|
disease |
BEFREE |
In the GAIN MDD study, two SNPs were associated with MDD: C5orf20 (rs12520799; P=0.038; odds ratio (OR) AT=1.10, 95% CI 0.95-1.29; OR TT=1.21, 95% confidence interval (CI) 1.01-1.47) and NPY (rs16139; P=0.034; OR C allele=0.73, 95% CI 0.55-0.97), constituting a direct replication of previously identified SNPs.
|
20351714 |
2011 |
Major Depressive Disorder
|
0.380 |
Biomarker
|
disease |
PSYGENET |
Among 44 individuals with MDD and 137 healthy controls, 152 (84%) had an NPY genotype classified as low, intermediate, or high expression according to previously established haplotype-based expression data.
|
21300944 |
2011 |
Major Depressive Disorder
|
0.380 |
Biomarker
|
disease |
BEFREE |
Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.J. Psychiatr.Res.38, 113-121).
|
19264362 |
2009 |
Major Depressive Disorder
|
0.380 |
Biomarker
|
disease |
BEFREE |
Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.
|
14757324 |
2004 |